Search

JBT Corporation Declares Quarterly Dividend

JBT Corporation Declares Quarterly Dividend

PR Newswire

CHICAGO, May 15, 2020 /PRNewswire/ — JBT Corporation (NYSE: JBT) announced that on May 15, 2020 its Board of Directors declared a quarterly cash dividend of $0.10 per share of outstanding common stock. The dividend will be payable on June 11, 2020 to stockholders of record at the close of business on May 28, 2020.

JBT Corporation (NYSE: JBT) is a leading global technology solutions provider to high-value segments of the food & beverage industry with focus on proteins, liquid foods and automated system solutions. JBT designs, produces and services sophisticated products and systems for multi-national and regional customers through its FoodTech segment. JBT also sells critical equipment and services to domestic and international air transportation customers through its AeroTech segment. JBT Corporation employs approximately 6,400 people worldwide and operates sales, service, manufacturing and sourcing operations in more than 25 countries. For more information, please visit www.jbtc.com.

Investors & Media:

Megan Rattigan

(312) 861-6048

 

Cision View original content:http://www.prnewswire.com/news-releases/jbt-corporation-declares-quarterly-dividend-301060287.html

SOURCE JBT Corporation



Contract Updates

Intertrade Limited (Cedar Rapids, Iowa) – $9,272,637

Intertrade Limited, Cedar Rapids, Iowa, has been awarded a maximum $9,272,637 firm-fixed-price contract for F-16 generator controls. This was a sole-source acquisition using justification 10 U.S. Code 3204 (a)(1), as stated in Federal Acquisition Regulation 6.302-1. This is a four-year…


Cottonwood Inc. (Lawrence, Kansas) – $44,370,000

Cottonwood Inc.,** Lawrence, Kansas, has been awarded a maximum $44,370,000 firm-fixed-price, indefinite-quantity contract for aircraft cargo tie down straps. This was a sole-source acquisition using justification 10 U.S. Code 3204 (a)(5), as stated in Federal Acquisition Regulation 8.7. This is…


Teva Pharmaceuticals USA Inc. (Parsippany, New Jersey) – $46,087,497

Teva Pharmaceuticals USA Inc., Parsippany, New Jersey, has been awarded a maximum $46,087,497 modification (P00009) exercising the third one-year option period of a five-year base contract (SPE2DP-20-D-0002) with five one-year option periods for adenovirus type 4 and type 7 vaccines.…


Northrop Grumman Systems Corp. (Oklahoma City, Oklahoma) – $64,111,631

Northrop Grumman Systems Corp., Oklahoma City, Oklahoma, has been awarded an estimated $64,111,631 delivery order (SPRTA1-26-F-0034) and modification (P00015) to a four-year subsumable base contract (SPRTA1-19-D-0001) with one five-year option period for additional pricing for the manufacture and production of…